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Xingxu Cao*, Fengwei Zhang, Lingling Wang, Hao Jing and Naiyan LiAbstract
Ruptured sinus of the valsalva aneurysm (RSVA ) is a rare cardiac anomaly. Nearly 80% of patients will have
symptom when RSVA ruptures into one of the cardiac chambers. The conventional treatment of RSVA is surgical
repair under cardio-pulmonary bypass (CPB) or percutaneous catheter closure. Here, we present one case of RSVA
undergo transthoracic minimally invasive closure, which is a novel methods for the treatment of RSVA. We describe
a thirty four-year-old Asian man with chest pain and palpitation for 3 days. Echocardiography showed that RSVA
presented in the right coronary cusp. The sinus opened into the right atrium, and the diameter of the opening was
5 mm. The opening was successfully closed by transthoracic minimally invasive closure with a ventricular septal
defect (VSD) occluder.
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RSVA is a rare congenital heart disease, which usually
occurs in adolescence or early adulthood. Most patients
with RSVA will have symptom when RSVA ruptures into
one of the cardiac chambers. Echocardiography can accur-
ately demonstrate the defect and help in establishing
the diagnosis. Surgical repair under CPB or percutaneous
catheter closure has been the traditional treatment for
RSVA. Here, we report the first case of RSVA closed by
transthoracic minimally invasive closure with a VSD
occluder.Case presentation
A thirty four-year-old Asian man was admitted to our
department with chest pain and palpitation for 3 days.
His past medical history was unremarkable. There was no
history of syncope. Clinical examination revealed tachycar-
dia, short breath, high volume pulse with blood pressure
of 110/55 mmHg. Auscultation revealed a louder and
longer continuous diastolic murmur at the left third
intercostal edge. Moist rale were heard in the bilateral
lung fields. Echocardiography showed that RSVA was* Correspondence: cxingxu@163.com
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reproduction in any medium, provided the orpresent in the right coronary cusp. The sinus opened
into the right atrium, and the diameter of the opening
was 5 mm. There was no aortic regurgitation.
We addressed all treatment ways to the patient. To
the patience preoperative, including the procedure and
complications. This patience worried about cardiopul-
monary bypass and the trauma by whole thoracotomy.
And also he did not want to undertake the risking of
reoperation as the closure failing with percutaneous
intervention. After informed consent, patient agreed for
the transthoracic closure.
The surgery was performed under general anesthesia
with endotracheal intubation. Intraoperative transesoph-
ageal echocardiography (TEE) was performed to monitor
the procedure. The maximal diameter of the opening of
the RSVA was measured by TEE (Figure 1). The distance
between the aortic opening site of the RSVA and the
right or left coronary ostium was also measured. Sternum
upper segment “J form” incision was made to expose
the heart. After the pericardium was opened, heparin
(1 mg/kg) was administered. Draw a straight line from the
opening to the right coronary sinus. The intersection point
between the line and ascending aorta was chosen for the
puncture point. A guide wire with a soft and floppy end
was placed into the right atrium through the rupture. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
Figure 1 The maximal diameter of the aortic opening of the
RSVA was measured on multi-plane TEE images. There was no
significant aortic valve regurgitation.
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alloy material CO, LTD, shanghai, China) was sent into
the right atrium along the guide wire. A VSD occluder
(shape memory alloy material co., LTD, shanghai, China)
2 mm larger than the maximal diameter of the RSVA
opening was implanted along the sheath. The first disc
was opened in the right atrium and was pulled back
to anchor at the rupture site, then another disc was
opened. When the left to right shunt disappeared, the
rest of the device was deployed (Figure 2). The whole
procedure was guided and monitored by TEE. Aortic
valve regurgitation or residual shunt was exclude before
detaching the device. After detaching the device fromFigure 2 A VSD occluder was advanced along the sheath. When the le
any significant aortic valve regurgitation or residual shunt.the delivery cable, TEE was repeated to evaluate the
position of the occluder, residual shunt and aortic valve
function. The patient received aspirin (100 mg per day)
for a six months period and follow-up. Transthoracic
echocardiography was examined at intervals of 1, 3 and
6 months after discharge. The result was satisfactory.
There was no significant complications.
Discussion
RSVA is a rare congenital cardiac anomaly, which usually
occurs in adolescence or early adulthood. RSVA is often
caused by congenital weakness of the wall of the sinus. It
can lead to progressive dilatation and ultimately rupture
into the cardiac chambers or the mediastinum [1]. Patients
with the unruptured aneurysm of the sinus of Valsalva
usually do not have any symptom, but nearly 80% of the
patients will have symptom when RSVA ruptures into one
of the cardiac chambers [2]. The conventional treatments
of RSVA mainly include surgical repair with patch closure
under CPB and percutaneous catheter closure with
occluder. Although the mortality is low, the injure of
the surgery and cardiopulmonary bypass is significant
to patients [3,4]. Percutaneous catheter closure of RSVA
was first described by Cullen in 1994, which has been
widely used in the treatment of ruptured aortic aneurysm
recently [5,6]. But percutaneous catheter closure was
complex to transit to conventional sternotomy when
closure was failed.
In order to overcome these problems, we applied
the novel method of transthoracic minimally invasive
closure with VSD occluder to close the opening of the
RSVA without CPB (Figure 3). And the early and follow-ft to right shunt disappeared, the device was deployed. There was not
Figure 3 There were transthoracic minimally invasive closure devices. A was the puncture needle; B was the guide wire with a soft and
floppy end; C was the livery sheath; D was the vsd occluder.
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form” incision was made to reduce the trauma and keep
the stability of sternum. Transthoracic closure gets rid of
the limitation of vascular conditions and the X-ray. The
delivery tract has shorter path and the occluder is easy
to release in a more stable position. In addition, we can
easily transit to the conventional sternotomy treatment
when the closure is failed. Apart from the feasibility of
the procedure, caution must be taken to exclude any
significant aortic valve regurgitation or residual shunt,
which may be associated with hemolysis due to high
pressure flow or infective endocarditis.
Conclusions
In summary, transthoracic minimally invasive closure of
RSVA may be another safe and efficient treatment for
RSVA patients without significant aortic regurgitation or
VSD.
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